Table 3.
Correlation between risk factors and cerebrovascular symptoms
| Asymptomatic patients | Symptomatic patients | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| N = 125 | N = 265 | p | p | OR (95% CI) | |
| 1st model | |||||
| Age, mean (SD) | 70.0 (7.3) | 69.4 (7.0) | 0.90 | 0.11 | 1.03 (0.99–1.06) |
| Gender | |||||
| M | 79 (63.2%) | 194 (73.2%) | 0.06 | 0.02 | 0.57 (0.35–0.92) |
| F | 46 (36.8%) | 71 (28.8%) | |||
| Hypertension | 73 (58.4%) | 198 (74.7%) | 0.001 | 0.004 | 1.98 (1.24–3.17) |
| Diabetes | 29 (23.2%) | 65 (24.5%) | 0.80 | 0.86 | 0.96 (0.56–1.62) |
| Smoking habit | 75 (60.0%) | 152 (57.4%) | 0.66 | 0.31 | 0.78 (0.49–1.25) |
| Dyslipidemia (high LDL-C) | 72 (57.6%) | 185 (69.8%) | 0.02 | 0.04 | 1.64 (1.03–2.61) |
| Obesity | 6 (4.8%) | 37 (14.0%) | 0.006 | 0.02 | 0.34 (0.14–0.86) |
| 2nd model | |||||
| Metabolic syndrome | 30 (24.0%) | 93 (35.2%) | 0.03 | 0.04 | 1.71 (1.05–3.04) |
| Metabolic syndrome without obesity | 24 (20.2%) | 61 (26.3%) | 0.24 | 0.26 | 1.17 (0.71–1.88) |
| Metabolic syndrome with obesity | 6 (5.9%) | 33 (16.2%) | 0.01 | 0.01 | 3.15 (1.85–5.10) |